Table 5.
Estimated intervention effects of isoflavones conditioned on serum calcium levels on systolic blood pressure during treatment of women with isoflavones using amounts of genistein excreted in urine, as an example
Effects on systolic blood pressure (mmHg)* | |||||
---|---|---|---|---|---|
Genistein (GE), mg/h (percentile) | Calcium, mg/dL (percentile) | ||||
1.46 (100th) | 0.56 (90th) | −0.05 (50th) | −0.45 (10th) | −1.15 (0th) | |
0.77 (100th) | −13.07 | −5.06 | 0.37 | 3.93 | 10.16 |
0.22 (90th) | −2.69 | −1.05 | 0.07 | 0.80 | 2.08 |
−0.06 (50th) | 2.59 | 1.00 | −0.08 | −0.79 | −2.03 |
−0.14 (10th) | 4.10 | 1.58 | −0.13 | −1.25 | −3.21 |
−0.17 (0th) | 4.67 | 1.80 | −0.14 | −1.42 | −3.65 |
Intervention effect† | −17.74 | −6.86 | 0.51 | 5.35 | 13.81 |